Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan

Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan

<i>Background and Objectives:</i> Fenofibrate, a PPAR-α agonist, has been demonstrated to reduce the progression of diabetic retinopathy (DR) and the need for laser treatment in a FIELD (Fenofibrate Intervention and Event Lowering in Diabetes) study. However, in the subgroup of patients...

Full description

Bibliographic Details
Main Authors: Ying-Chieh Lin, Yu-Ching Chen, Jorng-Tzong Horng, Jui-Ming Chen
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Medicina
Subjects:
fenofibrate
diabetic retinopathy
type 2 diabetic
Online Access:https://www.mdpi.com/1010-660X/56/8/385

Similar Items

Similar Items